Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1880438 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $4.70Day −4.67%Mkt cap $169M1Y +339.3%Off 52W high −32.0%Vol (1Y) 132.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,477 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest6.8% of sh out |
| Days to cover9.9d |
| 13F net flow (QoQ)+7.00% |
| Top-10 13F concentration70.0% |
| Next report (est.)2026-08-10 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$34.6M |
| ROE−52.1% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+312.3% |
| 1Y+339.3% |
| 3Y−43.1% |
| 5Y−44.0% |
| 10Y−89.6% |
| Since incept. (ann.)−20.1% |
Total return through 2026-07-28 · series begins 2016-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)132.4% |
| Ann. volatility (3Y)110.1% |
| Sharpe (1Y)1.65 |
| Sharpe (3Y)0.46 |
| Max drawdown (1Y)−45.6% |
| Max drawdown (3Y)−95.4% |
| Beta (3Y vs SPY)−2.53 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| Vivo Capital, LLC | 3.2M | $11M | 8.76% | new |
| Commodore Capital LP | 2.3M | $8M | 6.48% | new |
| MILLENNIUM MANAGEMENT LLC | 2.2M | $8M | 6.17% | +2222.8% |
| Spruce Street Capital LP | 1.7M | $6M | 4.61% | new |
| Almitas Capital LLC | 1.5M | $5M | 4.11% | +0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.0M | $3M | 2.81% | new |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.0M | $3M | 2.78% | new |
| Woodline Partners LP | 993,671 | $3M | 2.76% | +580.7% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-11 | −$0.29 | — | — | — |
| 2025-09-30 | 2025-11-12 | −$0.31 | — | — | — |
| 2025-06-30 | 2025-08-12 | −$0.21 | — | — | — |
| 2025-03-31 | 2025-05-13 | −$0.35 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-10 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
